BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38745909)

  • 1.
    Torres-Llanos Y; Zabaleta J; Cruz-Rodriguez N; Quijano S; Guzmán PC; de Los Reyes I; Poveda-Garavito N; Infante A; Lopez-Kleine L; Combita AL
    Front Mol Biosci; 2024; 11():1385140. PubMed ID: 38745909
    [No Abstract]   [Full Text] [Related]  

  • 2. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
    Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
    Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2'-O methylation.
    Zhu Y; Xiao B; Liu M; Chen M; Xia N; Guo H; Huang J; Liu Z; Wang F
    Cell Mol Biol Lett; 2023 Oct; 28(1):89. PubMed ID: 37891494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer.
    Ouyang W; Ren L; Liu G; Chi X; Wei H
    PeerJ; 2019; 7():e6683. PubMed ID: 30972258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages.
    Li C; Chen Z; Gao J; Tang T; Zhou L; Zhang G; Zhang D; Shen C; Guo L; Fu T
    Front Oncol; 2022; 12():1017745. PubMed ID: 36483041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIR4435-2HG regulates cancer cell behaviors in oral squamous cell carcinoma cell growth by upregulating TGF-β1.
    Shen H; Sun B; Yang Y; Cai X; Bi L; Deng L; Zhang L
    Odontology; 2020 Oct; 108(4):553-559. PubMed ID: 32016787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA MIR4435-2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF-β1.
    Zhang H; Meng H; Huang X; Tong W; Liang X; Li J; Zhang C; Chen M
    Oncol Lett; 2019 Oct; 18(4):4016-4021. PubMed ID: 31516603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis.
    Shen X; Ding Y; Lu F; Yuan H; Luan W
    Am J Transl Res; 2020; 12(10):6381-6394. PubMed ID: 33194037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis.
    Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
    Front Immunol; 2022; 13():855078. PubMed ID: 35784328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis.
    Shen MY; Zhou GR; -Y Zhang Z
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1771-1777. PubMed ID: 32141545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression.
    Yang T; Li Y; Wang G; Guo L; Sun F; Li S; Deng X; Liu J
    Biomed Res Int; 2022; 2022():3858249. PubMed ID: 35993042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIR4435-2HG, miR-125b-5p, and Sema4D axis affects the aggressiveness of colorectal cancer cells.
    Yu M; Yi Z; Chen S; Chen X; Xie X
    Folia Histochem Cytobiol; 2022; 60(2):191-202. PubMed ID: 35730423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
    Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
    J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling.
    Wang H; Wu M; Lu Y; He K; Cai X; Yu X; Lu J; Teng L
    Aging (Albany NY); 2019 Sep; 11(17):6657-6673. PubMed ID: 31484163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MIR4435-2HG is a potential early diagnostic marker for ovarian carcinoma.
    Gong J; Xu X; Zhang X; Zhou Y
    Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(9):953-959. PubMed ID: 31435668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.
    Ke J; Wang Q; Zhang W; Ni S; Mei H
    Am J Transl Res; 2022; 14(8):5441-5454. PubMed ID: 36105009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis.
    Xiao Y; Bao Y; Tang L; Wang L
    J Orthop Surg Res; 2019 Aug; 14(1):247. PubMed ID: 31387631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a.
    Kong Q; Liang C; Jin Y; Pan Y; Tong D; Kong Q; Zhou J
    Cell Mol Biol Lett; 2019; 24():26. PubMed ID: 30988676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
    Gao LF; Li W; Liu YG; Zhang C; Gao WN; Wang L
    Front Oncol; 2021; 11():661288. PubMed ID: 34532282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
    Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
    J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.